Company
LaSara Medical Group
LaSara Medical Group publishes compounded semaglutide and compounded tirzepatide, from $299 to $399 a month.
- 2 programs
- 2 molecules
- 2 readings
Read from lasara.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to LaSara Medical Group
We earn nothing from this link. LaSara Medical Group has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · 1 month
first month, including the required fees on record · 1 month
Terms
Not yet checked: pharmacy, membership, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Homepage claims nationwide reach with a footnoted asterisk ('across the country.*') whose footnote text did not appear anywhere in the fetched output, so this is recorded as not-found rather than all-50 — the exact scope/exclusions are unknown. Tirzepatide page explicitly says 'Every vial meets federal safety and purity standards,' confirming vial form for tirzepatide; the semaglutide product page never uses the word vial, pen, or syringe, so its form is recorded as not-disclosed.
Before you act
Cite this
Treatment Registry. (2026). LaSara Medical Group: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/lasara